InvestorsHub Logo
Followers 831
Posts 120032
Boards Moderated 17
Alias Born 09/05/2002

Re: DC15 post# 2851

Thursday, 01/25/2024 10:57:30 AM

Thursday, January 25, 2024 10:57:30 AM

Post# of 3017
PFE would probably argue for "apportionment" if the case reached the stage of awarding damages, but it seems like a weak counter since ritonavir is not an active agent against COVID and it is only in the mix because of the pharmacokinetic deficiencies of nirmatrelvir.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News